Pharmafile Logo
Pharmafocus logo
Advanced Search

avastin

Showing 15 posts of 94 posts found.

Roche’s Avastin set for new ovarian cancer indication in Europe

September 26, 2011
Sales and Marketing avastin, ovarian cancer

Roche’s Avastin has gained the backing of European regulatory advisors for a new indication in ovarian cancer. The European Medicines …

News
Roche's Avastin

Avastin faces greater scrutiny over eye disease use

September 23, 2011
Sales and Marketing avastin, macular oedema

The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …

News

Roche to show new cancer data at European congress

September 20, 2011
Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …

News

NICE rejects three bowel cancer drugs

September 5, 2011
Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer

NICE says three treatments – Roche’s Avastin, Merck KgAa’s Erbitux and Amgen’s Vectibix – are all not cost effective in …

News

EMA extends Avastin breast cancer licence

July 1, 2011
Sales and Marketing avastin, breast cancer, metastatic breast cancer

The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …

News
Roche's Avastin (bevacizumab)

FDA advisers reject Avastin appeal

June 30, 2011
Sales and Marketing FDA, avastin

An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …

News
Roche’s Avastin (bevacizumab)

NHS failed to use extra cancer drug funds

June 17, 2011
Sales and Marketing Cancer, Cancer Drugs Fund, Erbitux, avastin

The million pound fund set up to increase NHS uptake of new cancer drugs was widely underused, with just over …

News

Government wrong to push for Avastin in eye disease, says charity

May 12, 2011
Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD

The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …

News
Roche's Avastin (bevacizumab)

Avastin as effective as Lucentis in eye disease

May 4, 2011
Research and Development Lucentis, avastin, off label, wet AMD

Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …

News
Roche's Avastin (bevacizumab)

Avastin’s breast cancer use to continue in Europe

March 2, 2011
Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel

Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …

News
Roche's Avastin (bevacizumab)

NICE yes for Votrient, no to Avastin

February 23, 2011
Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …

News

Roche eyes ovarian cancer expansion for Avastin

February 8, 2011
Sales and Marketing Cancer, Roche, avastin, bevacizumab, ovarian cancer

Roche has submitted an EU marketing authorisation for Avastin for the treatment of ovarian cancer and plans to file the …

News
Roche's Avastin (bevacizumab)

Survey shows doctors support FDA Avastin decision

February 7, 2011
Sales and Marketing FDA, Roche, Sermo, avastin, bevacizumab

A survey of US doctors suggests that a majority support the FDA’s decision to take away Avastin’s licence for use …

News
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011
Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …

News
Avastin (bevacizumab) packs

Study highlights Avastin heart failure risk

January 6, 2011
Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer

A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …

News

Latest content

BioGen to acquire Human Immunology Biosciences for $1.15bn

May 23, 2024

Merck to acquire Mirus Bio for $600m

May 23, 2024

Rare disease clinical trials: the urgent need for patients to be heard

May 22, 2024

Sustainability in pharma

May 22, 2024

Sanofi, Formation Bio and OpenAI enter AI collaboration

May 22, 2024